This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_EYE_BRAIN_NEURO_EXALLC for full statistics.
Malignant neoplasm of eye, brain and central nervous system
C3_EYE_BRAIN_NEURO
brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1613 |
6. Filter based on genotype QC (FinnGen only) |
1613 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of eye, brain and central nervous system
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1613 | 719 | 894 |
| Unadjusted period prevalence (%) | 0.33 | 0.25 | 0.39 |
| Median age at first event (years) | 58.44 | 55.72 | 60.63 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1473
- Matched controls
- 14728
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N03AX14
ATC
levetiracetam; systemic
51.7
323.0
521
154
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
45.6
323.0
414
125
H02AB02
ATC
dexamethasone; systemic
33.4
323.0
924
706
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
342.0
323.0
342
13
130
Kela drug reimbursment
Malignant tumour
26.8
323.0
784
600
L01AX03
ATC
temozolomide; systemic
1336.7
323.0
623
8
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
26.3
323.0
587
362
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
541.6
323.0
721
26
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
24.7
323.0
719
548
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
1093.4
284.1
269
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
35.6
275.8
361
133
A04AA02
ATC
granisetron; systemic, transdermal
16.6
265.5
454
385
ZXC95
NOMESCO Finland
Use of surgical navigator
70.3
245.6
280
49
WF002
NOMESCO Finland
Radical radiotherapy
16.0
225.8
389
324
A03FA01
ATC
metoclopramide; systemic, rectal
7.0
223.8
695
1659
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
604.9
216.0
209
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
799.4
215.5
207
*
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
226.0
210.5
213
11
WF003
NOMESCO Finland
Adjuvant radiotherapy
19.8
193.8
303
190
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
27.7
190.6
266
116
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
1009.5
185.6
178
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
26.4
183.0
259
118
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
74.6
181.9
206
32
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
+∞
178.9
168
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
265.1
164.0
165
7
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
444.6
162.9
160
*
Z51.5
ICD-10 Finland
Palliative care
10.9
160.3
330
381
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
850.9
158.6
153
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
151.7
143
*
AA1AD
NOMESCO Finland
CT of head and brain
4.8
151.2
663
2141
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
136.6
129
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
135.5
128
*
XX3DW
NOMESCO Finland
Time consuming IT work
6.6
134.0
387
749
N03AF02
ATC
oxcarbazepine; oral
14.7
133.8
234
187
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
133.4
126
*
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
106.3
132.8
144
15
C69.30
ICD-10 Finland
Malignant tumor of the chorioidea without histology
292.5
132.5
133
5
A04AA01
ATC
ondansetron; systemic, rectal
8.7
130.5
304
426
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
14.7
126.1
220
174
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
56.2
124.0
147
29
CKE65
NOMESCO Finland
Removal of brachytherapeutic plate from eye
644.5
122.1
119
*
CKE60
NOMESCO Finland
Brachytherapy of choroid and retina
644.5
122.1
119
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.7
116.3
475
1352
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
316.2
115.9
116
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
113.0
107
*
ZXC40
NOMESCO Finland
Use of ultrasound
51.1
112.0
135
29
C69.32
ICD-10 Finland
Malignant tumor of the chorioidea melanoma
574.0
109.3
107
*
N03AX18
ATC
lacosamide; systemic
46.0
109.0
134
32
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
1116.8
107.8
104
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
107.6
102
*
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.3
104.2
305
583
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
218.9
99.8
102
5
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.2
99.3
237
336
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
18.7
98.6
155
92
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.7
97.1
243
370
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
95.9
91
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
93.8
89
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
42.4
91.4
114
29
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
90.6
86
*
XA800
NOMESCO Finland
Neuropsychological investigation
8.8
89.8
204
265
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
9.7
87.8
187
217
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
236.6
87.4
89
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
11.4
79.9
155
150
WX882
NOMESCO Finland
High dependency care
9.8
79.3
167
189
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.1
77.7
172
212
9680/3-C71.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of brain, NOS
+∞
76.7
73
*
N74
ICPC
Malignant neoplasm nervous system
397.3
76.5
76
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
75.6
642
3074
XCD10
NOMESCO Finland
Electrophysiological examination of eye
13.0
74.9
136
114
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
18.6
71.5
112
65
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
369.5
71.3
71
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
25.5
70.8
100
42
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
18.0
70.7
112
67
ZX095
NOMESCO Finland
Combined chemoradiotherapy
42.5
70.7
88
22
A02BC02
ATC
pantoprazole; systemic
2.7
68.9
1054
7039
N03AB02
ATC
phenytoin; systemic
21.4
68.5
102
51
C69.3
ICD-10 Finland
Malignant neoplasm: Choroid
+∞
68.3
65
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
+∞
68.3
65
*
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
183.6
67.6
70
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
13.4
67.6
121
98
8720/3-C69.9
ICD-O-3
Malignant melanoma, NOS, of eye, NOS
+∞
67.2
64
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
66.1
352
1188
8720/3-C69.3
ICD-O-3
Malignant melanoma, NOS, of choroid
+∞
65.1
62
*
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
65.1
62
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
60.7
64.3
75
13
AAA10
NOMESCO Finland
Biopsy through craniotomy
330.9
63.9
64
*
CK2L4
NOMESCO Finland
Wide-field/panoramic imaging of ocular fundus
41.7
63.3
79
20
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.3
62.8
208
445
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
+∞
60.8
58
*
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
28.3
60.7
83
31
N02AA05
ATC
oxycodone; systemic
3.4
58.0
331
1166
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
153.5
56.3
59
*
G40.10
ICD-10 Finland
Simple partial seizures
25.3
54.6
77
32
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
53.5
51
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
9.8
52.4
109
119
ZXM40
NOMESCO Finland
Use of fluorescent substance
114.2
51.1
55
5
C71.31
ICD-10 Finland
Malignant tumor of the parietal lobe grand II glioma
+∞
50.3
48
*
9400/3-C71.9
ICD-O-3
Astrocytoma, NOS, of brain, NOS
+∞
50.3
48
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
24.4
49.3
70
30
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
49.2
47
*
WX402
NOMESCO Finland
General anaesthesia
3.0
48.5
334
1325
9400/3-C71.1
ICD-O-3
Astrocytoma, NOS, of frontal lobe
+∞
48.2
46
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
21.9
47.0
69
33
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
472.1
46.6
46
*
8000/3-C71.9
ICD-O-3
Neoplasm, malignant of brain, NOS
+∞
46.1
44
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
45.8
391
1763
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
44.4
494
2563
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
44.0
42
*
H53.4
ICD-10 Finland
Visual field defects
9.2
43.4
93
107
9450/3-C71.1
ICD-O-3
Oligodendroglioma, NOS, of frontal lobe
+∞
42.9
41
*
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
41.9
40
*
WF004
NOMESCO Finland
Palliative radiotherapy
10.1
41.8
85
89
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
41.5
637
3821
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
10.9
40.6
79
76
N76
ICPC
Neoplasm nervous system unspecified
210.7
40.0
41
*
H02AB09
ATC
hydrocortisone; systemic
8.2
39.8
91
117
N03AF01
ATC
carbamazepine; oral, rectal
4.6
39.5
144
336
ZX090
NOMESCO Finland
Other technic of radiotherapy
7.0
39.1
100
152
N05BA09
ATC
clobazam; oral
19.2
38.6
59
32
WZC30
NOMESCO Finland
Teaching
2.9
38.5
266
1042
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.6
38.0
140
330
WX140
NOMESCO Finland
Parabulbar anesthesy
5.1
37.4
124
261
N03AG01
ATC
valproic acid; systemic, rectal
4.0
36.9
156
420
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.9
36.7
126
276
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
+∞
36.6
35
*
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
+∞
36.6
35
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
365.9
36.1
36
*
C69.39
ICD-10 Finland
Malignant tumor in chorioidea other or unspecified histology
355.4
35.1
35
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
18.9
34.6
53
29
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
34.5
33
*
A28
ICPC
Limited function/disability NOS
2.7
34.4
274
1164
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
11.3
34.2
65
60
WX872
NOMESCO Finland
Intensive care
4.2
33.7
136
350
N05CD08
ATC
midazolam; nasal, systemic
7.0
33.7
85
127
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
+∞
33.5
32
*
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
64.9
33.1
38
6
JN4BD
NOMESCO Finland
Extensive body CT
2.9
32.4
221
850
ZXE10
NOMESCO Finland
More than one and less than three hours
2.0
32.3
577
3575
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
6.9
31.7
81
123
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
17.2
31.6
50
30
TAB00
NOMESCO Finland
Lumbar puncture
4.6
31.5
113
259
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
31.4
30
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.2
31.1
77
112
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
34.2
31.0
40
12
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
29.3
28
*
9450/3-C71.9
ICD-O-3
Oligodendroglioma, NOS, of brain, NOS
+∞
29.3
28
*
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
57.9
29.2
34
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.8
28.9
131
373
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
15.8
28.3
46
30
C69.02
ICD-10 Finland
Malignant tumor in conjunctival melanoma
+∞
28.2
27
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
13.4
27.5
48
37
CFA20
NOMESCO Finland
Biopsy of conjunctiva
48.1
27.5
33
7
9510/3-C69.2
ICD-O-3
Retinoblastoma, NOS, of retina
+∞
27.2
26
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.0
26.7
168
611
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
22.9
26.6
38
17
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
15.8
26.5
43
28
R4150
NOMESCO Finland
Neuropsychological rehabilitation
14.6
26.2
44
31
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.1
26.2
107
278
N05CF01
ATC
zopiclone; oral
1.9
25.4
494
3091
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
51.0
25.3
30
6
G91.1
ICD-10 Finland
Obstructive hydrocephalus
36.3
25.3
32
9
Z2445
NOMESCO Finland
Psychologist
4.3
25.1
97
239
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
25.1
345
1887
C71.89
ICD-10 Finland
Overall malignant tumor of the brain other or unspecified histology
+∞
25.1
24
*
WX110
NOMESCO Finland
Local anesthesy
1.8
25.0
980
7711
XCK10
NOMESCO Finland
Photography of fundus of eye
2.6
24.7
191
787
A79
ICPC
Malignancy NOS
9.1
24.6
52
59
183
Kela drug reimbursment
Lamotrigin and topiramate
9.1
24.1
51
58
R4120
NOMESCO Finland
Occupational therapy
3.2
24.0
131
431
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
24.0
23
*
9401/3-C71.1
ICD-O-3
Astrocytoma, anaplastic, NOS, of frontal lobe
+∞
24.0
23
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
24.0
23
*
A98
ICPC
Health maint/preventive medicine
0.5
23.8
1108
12650
L03AA02
ATC
filgrastim; parenteral
5.4
23.4
72
140
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
23.0
264
1331
CAA30
NOMESCO Finland
Biopsy of orbit
84.8
22.7
25
*
CF2S4
NOMESCO Finland
Photography of conjunctiva
233.5
22.7
23
*
WX002
NOMESCO Finland
Sedation and analgesia
2.1
22.6
316
1730
WX704
NOMESCO Finland
Intubation
3.0
22.3
138
496
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
19.8
22.2
33
17
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.6
22.1
45
48
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.2
22.0
265
1360
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
21.9
21
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
+∞
21.9
21
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
8.9
21.7
46
53
ZXA00
NOMESCO Finland
Right side
1.9
21.7
408
2495
ZXA05
NOMESCO Finland
Left side
1.9
21.7
388
2332
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
223.2
21.6
22
*
AA5FG
NOMESCO Finland
Functional MRI examination of brain with high intensity magnet
116.8
21.6
23
*
R4110
NOMESCO Finland
Physiotherapy
1.9
21.6
405
2475
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
23.5
21.3
30
13
C71.82
ICD-10 Finland
Overall malignant tumor of the brain grade III glioma
+∞
20.9
20
*
1906B
ICD-9 Finland
Malignant neoplasm of eye, Choroid[MELANOMA CHORIOIDEAE]
+∞
20.9
20
*
9451/3-C71.1
ICD-O-3
Oligodendroglioma, anaplastic, NOS, of frontal lobe
+∞
20.9
20
*
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.1
20.1
114
385
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
20.0
150
604
C71.70
ICD-10 Finland
Malignant tumor of the brainstem without histology
+∞
19.8
19
*
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
19.8
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
19.8
19
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
12.9
19.4
34
27
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
19.3
254
1349
WW300
NOMESCO Finland
Transfer of autologic stem cells
15.0
18.9
31
21
9401/3-C71.9
ICD-O-3
Astrocytoma, anaplastic, NOS, of brain, NOS
+∞
18.8
18
*
PA7ST
NOMESCO Finland
Extensive medical infusion to cerebral artery
+∞
18.8
18
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
18.8
18
*
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
18.8
18
*
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
70.8
18.7
21
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
7.3
18.4
44
62
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
12.6
18.1
32
26
Z2446
NOMESCO Finland
Social worker
2.7
18.1
127
494
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
17.7
17
*
C71.02
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles grade III glioma
+∞
17.7
17
*
9401/3-C71.2
ICD-O-3
Astrocytoma, anaplastic, NOS, of temporal lobe
+∞
17.7
17
*
C71.65
ICD-10 Finland
Malignant tumor of the cerebellum primary neuroectodermal tumor
+∞
17.7
17
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.5
17.7
46
73
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
17.6
172
798
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
7.1
17.2
42
61
G40
ICD-10 Finland
Epilepsy
9.4
17.2
35
38
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
16.9
141
604
N05BA04
ATC
oxazepam; oral
1.8
16.7
342
2125
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
+∞
16.7
16
*
C71.81
ICD-10 Finland
Overall malignant tumor of the brain grade II glioma
+∞
16.7
16
*
C71.91
ICD-10 Finland
Malignant tumor in unspecified location in the brain grade II glioma
+∞
16.7
16
*
C69.21
ICD-10 Finland
Retina
+∞
16.7
16
*
WW500
NOMESCO Finland
Blood transfusion
3.3
16.6
85
268
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.4
16.5
36
44
B01AB10
ATC
tinzaparin; parenteral
2.8
16.4
111
420
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
9.4
16.2
33
36
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
16.9
16.1
25
15
XW000
NOMESCO Finland
Bone marrow biopsy
3.3
15.7
82
262
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
9.3
15.7
32
35
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
7.1
15.7
38
55
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
15.6
15
*
2151
FHL
Resection, big brain
+∞
15.6
15
*
3770
FHL
Placing a radiating plate on the surface of the eye with additional measures
+∞
15.6
15
*
9382/3-C71.1
ICD-O-3
Oligoastrocytoma, NOS, of frontal lobe
+∞
15.6
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.6
15
*
8000/3-C69.3
ICD-O-3
Neoplasm, malignant of choroid
+∞
15.6
15
*
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
26.6
15.6
21
8
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
5.7
15.5
44
79
Z3229
NOMESCO Finland
Other healthcare associate professional
2.3
15.3
142
642
CA1DG
NOMESCO Finland
Eye and orbita very extensive MRI examination with high intensity magnet
45.5
15.1
18
*
R4130
NOMESCO Finland
Speech therapy
4.6
14.8
51
114
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
16.7
14.8
23
14
C69.42
ICD-10 Finland
Malignant tumor of ciliary melanoma
+∞
14.6
14
*
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.6
14
*
3779
FHL
Other operations in this group include disc removal
+∞
14.6
14
*
PA7RT
NOMESCO Finland
Medical infusion to cerebral artery
+∞
14.6
14
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
+∞
14.6
14
*
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
14.6
14
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.1
14.6
166
826
CDC10
NOMESCO Finland
Enucleation of eye with insertion of prosthesis
151.4
14.5
15
*
C69.40
ICD-10 Finland
Malignant tumor of ciliary body without histology
151.4
14.5
15
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
14.3
253
1491
101
Kela drug reimbursment
Anterior pituitary hypofunction
10.2
14.0
27
27
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
14.0
598
4507
WX725
NOMESCO Finland
Noninvasive ventilation
3.0
13.9
81
281
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
11.5
13.8
25
22
G93.6
ICD-10 Finland
Cerebral oedema
75.8
13.6
15
*
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
6.7
13.6
34
52
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
13.6
13
*
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
26.0
13.4
18
7
Z3231
NOMESCO Finland
Registered nurse
1.6
13.1
385
2631
D69.5
ICD-10 Finland
Secondary thrombocytopenia
15.2
13.1
21
14
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
15.2
13.1
21
14
G40.89
ICD-10 Finland
Other epilepsy
11.1
13.0
24
22
N03AX23
ATC
brivaracetam; systemic
16.9
13.0
20
12
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
50.5
12.9
15
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
8.1
12.8
28
35
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
6.7
12.8
32
49
ZXM20
NOMESCO Finland
Intraoperative use of computerised tomography
10.6
12.8
24
23
XCK00
NOMESCO Finland
Perimetry
2.5
12.7
103
433
L28
ICPC
Limited function/disability (L)
1.8
12.7
216
1254
9470/3-C71.6
ICD-O-3
Medulloblastoma, NOS, of cerebellum, NOS
+∞
12.5
12
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
12.5
12
*
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.5
12
*
C69.20
ICD-10 Finland
Retina
+∞
12.5
12
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
12.5
12
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
12.5
12
*
C69.03
ICD-10 Finland
Malignant tumor of conjunctival carcinoma
+∞
12.5
12
*
C69.09
ICD-10 Finland
Malignant tumor in conjunctival other or unspecified histology
+∞
12.5
12
*
N03AX22
ATC
perampanel; oral
20.2
12.5
18
9
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
131.1
12.5
13
*
Z51.0
ICD-10 Finland
Radiotherapy session
7.2
12.3
29
41
N28
ICPC
Limited function/disability (N)
5.2
12.3
37
72
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
4.2
12.2
45
109
D31.3
ICD-10 Finland
Benign neoplasm: Choroid
5.7
12.1
34
61
R51.80
ICD-10 Finland
Headache
1.9
12.0
193
1094
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.3
12.0
28
39
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
5.6
12.0
34
62
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
8.0
11.9
26
33
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.9
11.8
73
264
180
Kela drug reimbursment
Interferon alfa
19.1
11.6
17
9
G41.2
ICD-10 Finland
Complex partial status epilepticus
23.1
11.6
16
7
JN4CD
NOMESCO Finland
Very extensive body CT
2.9
11.5
68
239
AA5JS
NOMESCO Finland
Extensive PET-MRI of brain metabolism
+∞
11.5
11
*
C71.74
ICD-10 Finland
Malignant tumor of the brainstem ependyoma
+∞
11.5
11
*
C72.9
ICD-10 Finland
Malignant neoplasm: Central nervous system, unspecified
+∞
11.5
11
*
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
11.5
11
*
C71.7
ICD-10 Finland
Malignant neoplasm: Brain stem
+∞
11.5
11
*
PC2ET
NOMESCO Finland
Extensive embolisation of lesion of liver
120.9
11.4
12
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.1
11.2
43
108
XA400
NOMESCO Finland
EEG
8.1
11.1
24
30
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
11.0
128
2190
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
4.5
10.9
38
87
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.3
10.9
39
92
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
8.3
10.8
23
28
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
60.4
10.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
3.0
10.6
61
210
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.3
10.6
52
161
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
10.1
10.5
20
20
C69.99
ICD-10 Finland
Malignant tumor in unspecified localization in eye or other unspecified histology
110.8
10.4
11
*
CH2S4
NOMESCO Finland
Photography of iris
110.8
10.4
11
*
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
+∞
10.4
10
*
C70.0
ICD-10 Finland
Malignant neoplasm: Cerebral meninges
+∞
10.4
10
*
9591/3-C71.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of brain, NOS
+∞
10.4
10
*
9450/3-C71.3
ICD-O-3
Oligodendroglioma, NOS, of parietal lobe
+∞
10.4
10
*
XX7GT
NOMESCO Finland
Selective internal radio therapy (SIRT) with Yttrium
+∞
10.4
10
*
C69.60
ICD-10 Finland
Malignant tumor in orbit without histology
+∞
10.4
10
*
9382/3-C71.9
ICD-O-3
Oligoastrocytoma, NOS, of brain, NOS
+∞
10.4
10
*
9450/3-C71.2
ICD-O-3
Oligodendroglioma, NOS, of temporal lobe
+∞
10.4
10
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
10.4
10
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.8
10.4
67
250
WW409
NOMESCO Finland
Other aferesis
16.2
10.4
16
10
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
32.8
10.3
13
*
CDC00
NOMESCO Finland
Enucleation of eye
32.8
10.3
13
*
R93.0
ICD-10 Finland
Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
23.5
10.2
14
6
N18
ICPC
Paralysis/weakness
4.0
10.2
40
103
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
3.8
10.2
42
113
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
13.2
10.2
17
13
CS494
NOMESCO Finland
Other visual field testing
3.8
10.1
41
109
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
10.0
222
1392
AA5DR
NOMESCO Finland
Brain metabolism PET with CT
14.7
10.0
16
11
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.3
10.0
36
86
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
40.3
10.0
12
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.1
9.9
53
176
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
4.5
9.8
33
74
B01AB05
ATC
enoxaparin; parenteral
1.5
9.7
383
2782
N03AX11
ATC
topiramate; oral
3.5
9.7
43
124
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
55.4
9.7
11
*
A06AD11
ATC
lactulose; oral
1.7
9.6
193
1178
ZXY02
NOMESCO Finland
Neuropsychologist
10.1
9.5
18
18
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
15.1
9.5
15
10
Z90.0
ICD-10 Finland
Acquired absence of part of head and neck
15.1
9.5
15
10
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.1
9.5
50
164
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.2
9.5
48
153
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.9
9.5
149
838
SPAT1153
SPAT
Removal of sutures
1.5
9.5
403
2971
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
5.0
9.4
29
59
D33.43
ICD-10 Finland
Spinal cord
100.7
9.4
10
*
ZX131
NOMESCO Finland
Intrathecal
100.7
9.4
10
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
30.2
9.4
12
*
C71.92
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade III glioma
+∞
9.4
9
*
AA003
NOMESCO Finland
Adjuvant radiotherapy of brain
+∞
9.4
9
*
C71.61
ICD-10 Finland
Malignant tumor of cerebellum grade II glioma
+∞
9.4
9
*
8720/3-C69.0
ICD-O-3
Malignant melanoma, NOS, of conjunctiva
+∞
9.4
9
*
C71.42
ICD-10 Finland
Malignant tumor of the occipital lobe grade III glioma
+∞
9.4
9
*
C71.79
ICD-10 Finland
Malignant tumor of the brainstem other or unspecified histology
+∞
9.4
9
*
C69.29
ICD-10 Finland
Retina
+∞
9.4
9
*
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
10.7
9.3
17
16
WX892
NOMESCO Finland
Monitored bed care
2.0
9.2
116
600
H53.2
ICD-10 Finland
Diplopia
2.9
9.2
53
184
R41.0
ICD-10 Finland
Disorientation, unspecified
3.0
9.1
52
179
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
9.1
88
408
ZXD05
NOMESCO Finland
Urgent procedure
1.5
9.1
418
3128
CD2S4
NOMESCO Finland
Photography of eye
9.1
9.0
18
20
Z97.0
ICD-10 Finland
Presence of artificial eye
36.9
9.0
11
*
Z2221
NOMESCO Finland
Medical doctor
1.5
9.0
362
2635
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
24.2
8.9
12
5
XX4AW
NOMESCO Finland
NA
24.2
8.9
12
5
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
8.0
8.9
19
24
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
8.9
659
7812
F80.1
ICD-10 Finland
Expressive language disorder
6.9
8.8
21
31
R50.9
ICD-10 Finland
Fever, unspecified
1.7
8.8
189
1174
ZXD35
NOMESCO Finland
Usual procedure
2.8
8.8
56
208
SPAT1229
SPAT
Assessment of need for aid
2.0
8.7
108
556
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.4
8.6
30
70
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.5
8.6
38
110
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.4
8.6
41
937
WX730
NOMESCO Finland
Conventional respirator
3.7
8.6
35
95
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.6
8.5
125
2027
TPX15
NOMESCO Finland
Removal of vascular injection port
10.1
8.5
16
16
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
10.1
8.5
16
16
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
8.4
142
816
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
90.6
8.4
9
*
C69.2
ICD-10 Finland
Malignant neoplasm: Retina
+∞
8.3
8
*
C69.63
ICD-10 Finland
Malignant tumor of orbital carcinoma
+∞
8.3
8
*
9400/3-C71.0
ICD-O-3
Astrocytoma, NOS, of cerebrum
+∞
8.3
8
*
C71.49
ICD-10 Finland
Malignant tumor in occipital lobe other or unspecified histology
+∞
8.3
8
*
2159
FHL
Other measure in this category
+∞
8.3
8
*
1905A
ICD-9 Finland
Malignant neoplasm of eye, Retina[RETINOBLASTOMA RETINAE]
+∞
8.3
8
*
9445/3-C71.9
ICD-O-3
Glioblastoma, IDH-mutant of brain, NOS
+∞
8.3
8
*
9391/3-C71.7
ICD-O-3
Ependymoma, NOS, of brain stem
+∞
8.3
8
*
19003
ICD-8 Finland
Malignant neoplasm of eye, Retinae
+∞
8.3
8
*
WX142
NOMESCO Finland
Sub-tenon anesthesy
8.6
8.3
17
20
JN4AD
NOMESCO Finland
Body CT examination
2.0
8.3
105
545
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
10.8
8.3
15
14
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.2
8.3
30
73
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.0
8.3
101
518
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
0.7
8.3
321
4247
H47.1
ICD-10 Finland
Papilloedema, unspecified
9.5
8.3
16
17
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.6
8.2
59
235
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.1
8.1
95
477
XX8XW
NOMESCO Finland
NA
17.3
8.1
12
7
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
22.1
8.0
11
5
C10AX09
ATC
ezetimibe; oral
0.4
8.0
36
839
Z3226
NOMESCO Finland
Physiotherapist
1.6
7.9
238
1619
N02BE01
ATC
paracetamol; systemic, rectal
1.4
7.9
1146
10446
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
7.8
122
1950
A07AA02
ATC
nystatin; oral
2.1
7.8
82
395
G91.0
ICD-10 Finland
Communicating hydrocephalus
8.5
7.8
16
19
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
8.5
7.8
16
19
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
7.8
75
349
H01AC01
ATC
somatropin; parenteral
9.5
7.8
15
16
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.5
7.8
61
1175
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.8
7.8
49
180
E23.00
ICD-10 Finland
Panhypopituitarism
15.1
7.7
12
8
N03AF04
ATC
eslicarbazepine; oral
45.2
7.7
9
*
N80
ICPC
Head injury other
4.0
7.7
29
74
RS221
NOMESCO Finland
NA
3.9
7.7
30
79
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
4.8
7.6
24
51
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
18.5
7.6
11
6
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
10.1
7.5
14
14
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
80.5
7.4
8
*
AA5FK
NOMESCO Finland
Functional assessment (fMRI) of brain
80.5
7.4
8
*
1911X
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,EI HISTOLOGISTA VAHVISTUST]
80.5
7.4
8
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
80.5
7.4
8
*
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.5
7.4
66
1221
D43
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of brain and central nervous system
+∞
7.3
7
*
C71.73
ICD-10 Finland
Malignant tumor of the brain stem grade IV glioma
+∞
7.3
7
*
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
+∞
7.3
7
*
9400/3-C71.3
ICD-O-3
Astrocytoma, NOS, of parietal lobe
+∞
7.3
7
*
C71.63
ICD-10 Finland
Malignant tumor of cerebellum grade IV glioma
+∞
7.3
7
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
7.3
7
*
1BC01
NOMESCO Finland
NA
+∞
7.3
7
*
C69.45
ICD-10 Finland
Melanoma of iris
+∞
7.3
7
*
8000/3-C71.2
ICD-O-3
Neoplasm, malignant of temporal lobe
+∞
7.3
7
*
9530/3-C70.0
ICD-O-3
Meningioma, malignant of cerebral meninges
+∞
7.3
7
*
8000/3-C71.1
ICD-O-3
Neoplasm, malignant of frontal lobe
+∞
7.3
7
*
9591/3-C69.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of eye, NOS
+∞
7.3
7
*
19107
ICD-8 Finland
Malignant neoplasm of brain, Cerebelli
+∞
7.3
7
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.1
7.3
38
126
M03BX01
ATC
baclofen; systemic
3.7
7.3
30
83
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.3
7.3
66
299
CKA10
NOMESCO Finland
Biopsy of vitreous body
15.8
7.2
11
7
YNB10
NOMESCO Finland
Collection of stem cells for transplant
15.8
7.2
11
7
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
5.5
7.2
20
37
G81.9
ICD-10 Finland
Hemiplegia, unspecified
4.4
7.2
24
55
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
30.2
7.2
9
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
30.2
7.2
9
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
12.1
7.1
12
10
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
6.1
7.1
18
30
ZX080
NOMESCO Finland
Image guided radiotherapy
3.2
7.0
34
107
GD1AA
SPAT
NA
0.3
7.0
13
447
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
7.0
85
437
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.3
6.9
33
103
R03AC02
ATC
salbutamol; inhalant
0.7
6.9
445
5464
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.7
6.9
137
835
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.8
6.8
21
44
C07AB07
ATC
bisoprolol; oral
0.7
6.8
392
4902
G41.0
ICD-10 Finland
Grand mal status epilepticus
11.0
6.8
12
11
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
6.8
99
544
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
40.2
6.8
8
*
ZX000
NOMESCO Finland
Simple adjustment of radiotherapy with simulator or with therapeutic device - isocentric therapy
40.2
6.8
8
*
CAW99
NOMESCO Finland
Other operation on orbit
40.2
6.8
8
*
AAF30
NOMESCO Finland
Implantation of intraventricular injection device
40.2
6.8
8
*
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
16.8
6.7
10
6
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
16.8
6.7
10
6
XX1AD
NOMESCO Finland
Other CT-examination
7.2
6.7
15
21
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.1
6.7
72
353
AA5NK
NOMESCO Finland
Tractography within white matter of central nervous system
22.6
6.7
9
*
G06.0
ICD-10 Finland
Intracranial abscess and granuloma
22.6
6.7
9
*
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.3
6.6
56
247
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.7
6.6
13
15
C82.1
ICD-10 Finland
Follicular lymphoma grade II
6.9
6.5
15
22
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
3.7
6.5
26
71
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
70.1
6.4
7
*
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.0
6.3
*
159
102
Kela drug reimbursment
Diabetes insipidus
11.1
6.3
11
10
DFF20
NOMESCO Finland
Audiometry for children
9.3
6.3
12
13
2152
FHL
Extraction, big brain
18.1
6.3
9
5
9382/3-C71.2
ICD-O-3
Oligoastrocytoma, NOS, of temporal lobe
+∞
6.3
6
*
1911A
ICD-9 Finland
Malignant neoplasm of brain, Frontal lobe[AIVOJEN OTSALOHKON SYÖPÄ,ASTROCYTOMA (GR I-II)]
+∞
6.3
6
*
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
6.3
6
*
CAB00
NOMESCO Finland
Anterior orbitotomy with excision of lesion
+∞
6.3
6
*
19100
ICD-8 Finland
Malignant neoplasm of brain, Lobi frontalis
+∞
6.3
6
*
9391/3-C71.5
ICD-O-3
Ependymoma, NOS, of ventricle, NOS
+∞
6.3
6
*
1AC01
NOMESCO Finland
NA
+∞
6.3
6
*
9380/3-C71.2
ICD-O-3
Glioma, malignant of temporal lobe
+∞
6.3
6
*
9401/3-C71.3
ICD-O-3
Astrocytoma, anaplastic, NOS, of parietal lobe
+∞
6.3
6
*
C71.41
ICD-10 Finland
Malignant tumor of occipital lobe grade II glioma
+∞
6.3
6
*
C69.91
ICD-10 Finland
Malignant tumor in unspecified localization in the eye retinoblastoma
+∞
6.3
6
*
C71.66
ICD-10 Finland
Malignant tumor of the cerebellum medullobastoma
+∞
6.3
6
*
2312
FHL
Extirpation or destruction
+∞
6.3
6
*
9380/3-C71.1
ICD-O-3
Glioma, malignant of frontal lobe
+∞
6.3
6
*
C69.90
ICD-10 Finland
Malignant tumor in unspecified localization in eye without histology
+∞
6.3
6
*
C10AA05
ATC
atorvastatin; oral
0.7
6.2
289
3746
WC115
NOMESCO Finland
Cytostatic therapy of local tumor recidive with multiple drugs
26.8
6.2
8
*
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
0.6
6.2
72
1241
JN6AD
NOMESCO Finland
CT of torso and neck
3.9
6.2
23
59
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
6.2
100
571
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
6.2
72
364
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
7.7
6.1
13
17
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
7.7
6.1
13
17
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
6.1
92
513
AWE00
NOMESCO Finland
Reoperation for deep heamorrhage in surgery of the nervous system
12.6
6.1
10
8
CBA10
NOMESCO Finland
Biopsy of eyelid
4.9
6.1
18
37
N29
ICPC
Neurological sympt/complt other
3.1
6.0
31
103
AA1AA
NOMESCO Finland
Head X-ray examination
5.2
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
299
79
46.23
307.65
1.8
2.1
—
—
—
0
0
(4035726)
685
1046
10.64
307.65
1.4
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
534
1454
5.00
186.80
7.0
8.4
mmol/l
1.1
1.1
0.06
389
1142
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
533
1458
4.97
185.22
7.0
8.3
kpa
5.0
5.1
4.09
510
1400
(3027801) Oxygen [Partial pressure] in Arterial blood
533
1459
4.96
185.04
7.0
8.3
kpa
17.6
12.0
54.00
510
1403
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
152
0
+∞
161.20
1.1
0.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
134
84
17.31
159.23
1.1
1.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
587
1993
4.06
149.13
2.3
2.4
s
27.4
29.8
20.84
569
1931
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
134
127
11.42
124.59
2.1
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
179
260
7.62
119.34
2.1
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
187
291
7.14
117.05
2.1
1.4
e6/l
2923.6
1323.9
0.63
154
231
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
186
291
7.09
115.82
2.0
1.3
e6/l
61.4
20.6
0.78
151
223
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
95
62
16.22
110.13
2.4
2.4
umol/l
53.5
53.3
0.01
86
50
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
72
24
31.35
109.88
1.6
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
125
130
10.34
108.76
1.9
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1085
6540
3.01
93.95
13.9
6.4
umol/l
10.5
11.8
3.19
1065
6201
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
84
62
14.24
90.90
1.8
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
165
294
6.14
89.98
1.9
1.3
mmol/l
3.7
3.8
0.30
158
274
(3033658) Prothrombin time (PT) actual/Normal
675
3232
2.87
89.34
4.2
4.2
%
94.4
89.2
7.21
655
3156
(3044640) Blood type and Crossmatch panel - Blood
769
4025
2.74
84.51
2.6
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
801
4310
2.71
82.84
9.4
5.8
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
960
5668
2.71
82.01
8.0
6.4
mmol/l
1.2
1.2
8.33
930
5142
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
729
3814
2.66
78.76
2.7
2.1
u/l
144.5
249.0
3.28
708
3589
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1004
6215
2.63
75.35
8.8
7.1
mmol/l
1.2
1.2
4.32
890
5251
(40768804) Tissue Pathology biopsy report
852
4884
2.58
75.10
3.0
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1128
7512
2.67
70.70
8.2
5.0
mmol/l
6.7
6.7
0.19
1099
7035
(3013650) Neutrophils [#/volume] in Blood by Automated count
1107
7311
2.64
70.50
19.2
8.9
e9/l
4.0
4.2
1.92
996
6376
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
82
89
9.65
68.84
1.9
1.3
mmol/l
2.4
1.9
2.84
76
84
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
596
3060
2.50
64.01
2.5
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
95
139
7.20
62.34
2.1
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
975
6308
2.38
61.05
10.3
5.8
e9/l
0.6
0.6
6.37
866
5444
(3011412) CD3 cells [#/volume] in Blood
85
113
7.88
60.66
1.9
2.5
e9/l
1.0
1.1
0.17
64
67
(3022096) Basophils/100 leukocytes in Blood
916
5782
2.35
60.55
10.3
6.0
%
0.5
0.7
13.39
896
5399
(3006315) Basophils [#/volume] in Blood
975
6331
2.37
60.19
10.3
5.8
e9/l
0.0
0.0
20.16
865
5463
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
46
23
20.56
60.14
7.4
5.5
umol/l
46.6
44.1
0.20
39
18
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
72
79
9.49
59.89
1.9
2.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
931
5984
2.31
58.04
10.6
6.2
%
8.9
8.7
1.06
913
5606
(3013115) Eosinophils [#/volume] in Blood
990
6539
2.33
57.72
10.9
6.1
e9/l
0.1
0.2
46.00
880
5745
(3006504) Eosinophils/100 leukocytes in Blood
926
5960
2.30
57.24
10.4
5.9
%
2.1
2.9
25.08
905
5551
(3019198) Lymphocytes [#/volume] in Blood
979
6478
2.30
56.22
10.4
5.8
e9/l
1.6
1.9
3.56
875
5703
(3002030) Lymphocytes/100 leukocytes in Blood
934
6130
2.24
53.74
10.5
6.0
%
24.6
27.8
14.91
913
5721
(3002173) Hemoglobin [Mass/volume] in Arterial blood
303
1205
2.86
53.39
9.5
9.3
g/l
127.1
122.0
4.36
290
1164
(3018010) Neutrophils/100 leukocytes in Blood
922
6031
2.23
53.34
10.1
5.8
%
60.2
57.2
10.18
899
5652
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
70
86
8.46
53.29
1.8
2.4
%
11.5
15.8
1.27
33
44
(3016502) Oxygen saturation in Arterial blood
320
1321
2.77
52.47
9.4
8.7
%
97.9
95.6
21.24
305
1278
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
51
45
11.67
49.29
3.4
3.2
umol/l
29.1
32.5
0.68
42
31
(3032352) Blasts [#/volume] in Cerebral spinal fluid
34
13
26.70
49.15
1.3
4.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
328
1420
2.64
48.66
5.4
4.2
u/l
249.9
246.3
0.14
318
1343
(3036481) Cortisol [Moles/volume] in Serum or Plasma
285
1151
2.79
48.46
2.7
2.1
nmol/l
329.7
366.8
2.79
271
1057
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1019
12739
0.46
46.72
3.8
4.8
mmol/l
2.8
2.7
2.34
924
11714
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
997
12514
0.47
44.67
3.6
4.4
mmol/l
4.7
4.6
1.23
908
11589
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
58
73
8.20
43.24
1.3
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
990
12421
0.47
43.21
3.5
4.3
mmol/l
1.4
1.4
0.94
902
11435
(3012095) Magnesium [Moles/volume] in Serum or Plasma
411
2080
2.31
42.81
4.1
3.9
mmol/l
0.8
0.8
4.90
388
1950
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
870
5905
2.03
41.58
4.6
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
552
3196
2.11
40.71
14.6
6.7
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
809
5398
2.00
40.06
6.3
5.1
g/l
34.7
35.5
3.78
767
5017
(3032080) INR in Blood by Coagulation assay
788
5226
1.99
39.54
5.7
9.5
inr
1.1
1.3
7.68
221
1515
(3023368) Bacteria identified in Blood by Culture
589
3555
2.03
38.32
4.7
4.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
92
207
4.65
38.19
2.9
5.7
umol/l
351.2
366.7
0.42
85
182
(3015377) Calcium [Moles/volume] in Serum or Plasma
664
4232
1.97
36.56
8.5
3.4
mmol/l
2.4
2.4
0.31
612
3702
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
44
53
8.51
33.95
2.2
1.2
%
64.6
80.2
—
18
8
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
35
31
11.52
33.64
1.7
2.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
259
1185
2.41
33.25
4.2
8.3
mmol/l
6.1
9.8
26.34
245
1131
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
972
11995
0.52
33.23
3.3
3.9
mmol/l
1.3
1.3
0.18
889
10978
(3018418) pH of Serum or Plasma
584
3668
1.93
32.71
4.3
4.1
ph
7.4
7.4
0.78
117
707
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
54
87
6.39
32.27
1.9
2.6
e6/l
531.8
583.1
0.16
46
77
(3014007) Fractional oxyhemoglobin in Arterial blood
199
815
2.64
32.24
5.9
10.4
%
95.8
93.9
8.90
199
809
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
53
84
6.49
32.17
1.9
2.6
e9/l
0.2
0.2
0.88
46
77
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
176
678
2.79
32.13
12.6
12.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
52
81
6.60
32.09
1.3
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
934
11630
0.53
32.08
4.7
5.7
mmol/mol
39.2
39.9
1.49
869
10757
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1207
9687
1.98
30.35
15.8
7.5
u/l
75.6
79.5
2.54
1174
9092
(3039000) Anion gap in Blood
98
279
3.68
29.63
17.7
8.4
mmol/l
10.6
11.4
2.10
85
251
(3018572) Chloride [Moles/volume] in Blood
98
280
3.66
29.47
17.7
8.3
mmol/l
105.9
105.4
0.30
85
252
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
68
151
4.66
28.67
1.2
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
66
144
4.74
28.42
1.2
1.1
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
188
798
2.53
28.17
13.5
7.5
mmol/l
25.4
24.5
2.61
172
748
(21494814) CD8 cells/100 lymphocytes in Specimen
35
42
8.50
27.06
1.7
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1025
12217
0.56
26.00
4.1
4.5
mmol/l
5.9
6.0
0.28
922
11108
(3019060) Gas panel - Arterial blood
191
847
2.42
25.98
11.3
5.2
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
30
33
9.24
24.77
2.0
1.2
%
15.5
15.5
—
12
6
(3047181) Lactate [Moles/volume] in Blood
111
389
2.99
23.99
16.3
7.2
mmol/l
1.6
1.3
1.50
97
339
(3021589) Normoblasts [#/volume] in Blood
771
5629
1.71
23.98
16.2
9.5
e9/l
0.0
0.0
0.02
638
4594
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
163
3313
0.43
22.97
1.6
1.7
mmol/l
1.4
1.4
0.02
141
2785
(3000991) Gas panel - Venous blood
224
1120
2.16
22.82
6.9
9.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
56
128
4.50
22.79
1.2
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
36
56
6.55
22.24
1.1
1.2
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
44
86
5.23
21.53
2.3
2.8
%
36.7
41.1
0.75
21
29
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
86
277
3.22
21.46
4.0
7.0
iu/ml
659.7
436.6
0.21
15
40
(3003694) ABO and Rh group [Type] in Blood
518
3489
1.71
20.97
1.3
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
204
1015
2.16
20.96
4.6
4.2
%
1.6
0.9
3.88
98
302
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
117
464
2.64
20.03
1.9
2.2
ug/l
327.5
488.8
0.41
110
435
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
123
508
2.54
19.38
14.9
5.8
%
1.5
1.6
0.63
110
474
(3007930) Methemoglobin/Hemoglobin.total in Blood
120
502
2.50
18.40
15.2
5.9
%
1.1
0.9
4.66
107
469
(3021879) Hepatitis B virus core Ab [Presence] in Serum
187
945
2.11
18.38
1.4
1.5
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
38
76
5.10
18.13
1.1
1.1
u/l
1.3
1.1
0.73
22
37
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
46
112
4.20
17.31
3.5
2.5
nmol/l
17.1
19.6
0.89
46
103
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
627
8067
0.64
16.75
2.8
3.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
359
2305
1.72
16.74
4.2
3.1
mmol/l
2.4
2.5
0.57
325
2023
(1761868) Lipid panel - Serum or Plasma
295
4550
0.57
16.71
2.4
2.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
41
96
4.36
16.23
2.1
2.3
e6/l
687.5
792.5
0.32
15
39
(3023183) Ammonium ion [Moles/volume] in Plasma
80
298
2.77
15.49
1.9
3.5
umol/l
33.5
38.9
0.75
68
254
(3004809) Band form neutrophils/100 leukocytes in Blood
61
199
3.15
14.95
4.2
3.7
%
2.2
1.3
0.74
51
171
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
30
59
5.16
14.60
1.2
1.1
ng/l
1286.0
385.3
0.52
11
13
(3000060) B lymphocytes [#/volume] in Blood
23
35
6.65
14.49
2.0
2.9
e6/l
390.8
264.2
0.48
13
19
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
56
5.26
14.40
1.4
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
561
4144
1.54
14.40
5.8
3.3
u/l
34.4
38.6
0.43
539
3940
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
49
144
3.48
14.18
1.6
1.7
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
172
932
1.95
13.83
4.4
4.0
%
0.6
0.6
0.23
56
226
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
22
8.26
13.64
1.4
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
176
967
1.92
13.58
4.7
4.2
%
0.2
0.1
0.75
88
278
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
31
67
4.70
13.55
4.9
3.2
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
38
100
3.87
12.93
1.0
1.1
mg/l
685.8
282.1
0.83
32
87
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
32
74
4.39
12.90
1.2
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
39
105
3.78
12.85
1.1
1.1
mg/l
95.2
43.0
0.66
31
86
(3020682) Albumin/Creatinine [Ratio] in Urine
255
3870
0.59
12.83
3.6
4.1
mg/mmol
12.8
8.8
0.44
144
2498
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
316
2100
1.63
12.54
2.1
1.9
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
21
34
6.24
12.48
2.4
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
95
1926
0.46
12.39
1.2
1.2
u/ml
18.8
10.3
0.36
27
737
(3010813) Leukocytes [#/volume] in Blood
1325
14253
0.61
12.33
38.0
20.9
e9/l
6.9
6.7
1.91
1291
13846
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
28
6.85
12.31
1.0
1.2
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1325
14249
0.61
12.22
38.4
21.0
g/l
134.0
136.3
7.17
1309
14015
(3012516) Albumin [Mass/volume] in Urine
242
3681
0.60
12.16
3.0
3.3
mg/l
265.5
280.8
0.03
150
2407
(3026361) Erythrocytes [#/volume] in Blood
1325
14246
0.61
12.14
38.0
20.8
e12/l
4.4
4.5
16.11
1289
13840
(3035941) MCH [Entitic mass]
1325
14245
0.61
12.11
37.8
20.8
pg
30.7
30.3
15.03
1307
14013
(3024731) MCV [Entitic volume]
1325
14244
0.61
12.08
37.9
20.8
fl
91.6
90.9
8.06
1308
14014
(3007461) Platelets [#/volume] in Blood
1325
14238
0.61
11.92
38.0
20.9
e9/l
232.3
247.2
11.57
1293
13863
(3017143) Hepatitis C virus Ab [Presence] in Serum
234
1456
1.71
11.92
1.5
1.6
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
46
147
3.19
11.71
1.3
1.4
mosm/kgh2o
282.7
280.4
0.27
39
108
(3001122) Ferritin [Mass/volume] in Serum or Plasma
398
5374
0.66
11.70
2.5
2.8
ug/l
206.4
135.3
1.53
361
4935
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
42
129
3.32
11.40
3.0
2.5
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
193
1152
1.77
11.37
5.3
7.8
mmol/l
1.3
1.4
1.70
184
1105
(3009508) Creatinine [Moles/volume] in Urine
272
3965
0.62
11.29
3.0
3.3
mmol/l
8.6
7.8
1.52
215
3329
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
235
1487
1.68
11.21
2.0
1.8
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
21
38
5.59
11.18
1.1
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
170
983
1.82
11.14
2.8
2.9
g/l
8.5
10.6
10.28
155
904
(36304419) Bacteria [Presence] in Urine
464
3442
1.49
11.08
2.8
3.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
2033
0.50
11.07
1.2
1.2
iu/ml
27.7
31.1
0.16
37
619
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
12
11
10.98
11.07
1.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
62
4.41
11.00
1.3
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
473
3527
1.48
10.99
2.9
3.3
e6/l
0.5
0.5
0.00
372
2701
(4027681)
32
84
3.87
10.95
1.3
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
35
98
3.63
10.93
1.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
44
143
3.14
10.91
1.3
1.3
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
233
1483
1.67
10.86
2.0
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
139
763
1.90
10.73
1.4
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
484
3657
1.46
10.41
3.0
3.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
14
18
7.84
10.15
1.7
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
506
3872
1.45
10.13
2.9
3.4
e6/l
34.1
81.0
1.80
395
3024
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
139
3.08
10.12
4.3
4.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
36
110
3.32
9.88
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
83
392
2.18
9.70
1.7
1.7
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
257
1735
1.57
9.35
4.2
6.4
mmol/l
1.0
1.0
1.28
241
1603
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1031
11506
0.71
9.27
4.5
4.5
mu/l
1.7
2.1
1.90
949
10487
(3012501) Base excess in Blood by calculation
67
296
2.32
9.19
2.6
4.8
mmol/l
2.4
2.7
0.34
48
199
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
66
290
2.33
9.17
1.4
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
66
290
2.33
9.17
1.4
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
35
5.19
8.89
1.2
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
353
2577
1.47
8.86
2.6
2.8
mosm/kgh2o
541.2
555.6
0.62
310
2206
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
222
1468
1.59
8.80
3.1
3.1
umol/l
7.8
8.4
0.16
189
1293
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
99
3.28
8.64
1.4
1.6
promille
0.8
1.4
1.12
22
79
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
36
5.05
8.62
1.2
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
69
318
2.22
8.59
2.1
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
333
2418
1.48
8.56
3.2
3.8
ng/l
228.1
522.8
1.25
246
1900
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
37
126
2.98
8.53
1.7
1.8
—
—
—
0
0
(3036489) Thrombin time
93
483
1.98
8.48
2.8
2.6
s
22.4
21.6
0.38
81
436
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
12
16
7.55
8.42
1.1
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
16
7.55
8.42
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
75
361
2.13
8.39
2.6
4.4
ph
7.4
7.4
0.12
66
291
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
85
433
2.02
8.19
2.8
3.9
u/ml
0.4
0.3
0.80
59
246
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
69
326
2.17
8.10
2.1
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
22
55
4.04
8.08
1.1
1.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
41
153
2.72
8.03
1.8
1.6
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
945
8237
1.36
8.02
4.5
4.5
e6/l
3245.2
2329.9
0.11
13
128
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
39
4.66
7.88
1.2
1.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
601
4898
1.36
7.87
3.5
3.7
ng/l
27.8
57.5
1.73
451
3420
(3025159) Blasts/100 leukocytes in Blood
148
919
1.67
7.54
4.9
4.3
%
0.1
0.5
0.57
63
239
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
37
4.63
7.41
1.4
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
59
274
2.20
7.25
1.6
2.5
%
17.8
16.1
1.28
20
140
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
33
116
2.88
7.24
1.3
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
550
4471
1.35
7.16
3.4
3.9
e6/l
54.7
105.5
1.50
412
3237
(40760892) CBC W Ordered Manual Differential panel - Blood
365
2778
1.41
7.15
8.1
4.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
87
471
1.90
7.06
5.4
4.1
g/l
0.2
0.3
0.84
68
206
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
376
4775
0.72
6.89
3.6
4.7
ug/l
2.4
2.5
0.20
334
4274
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
254
1823
1.47
6.83
1.5
1.6
—
—
—
0
0
(40768441) Liver Pathology biopsy report
29
98
3.00
6.82
1.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
46
199
2.35
6.70
2.1
1.8
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
257
2.18
6.68
1.5
1.6
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
42
175
2.44
6.64
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
67
1239
0.52
6.52
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
198
2793
0.67
6.52
2.4
2.9
ug/l
0.8
0.8
0.02
119
1801
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
37
4.36
6.50
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
13
25
5.23
6.49
1.2
1.0
—
—
—
0
0
(44790048)
39
159
2.49
6.46
1.6
1.8
—
—
—
0
0
(44806118)
39
159
2.49
6.46
1.6
1.8
—
—
—
0
0
(44790049)
39
159
2.49
6.46
1.6
1.8
—
—
—
0
0
(44790047)
39
159
2.49
6.46
1.6
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
51
237
2.19
6.30
2.3
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
292
3812
0.71
6.22
3.2
4.1
%
22.6
21.3
0.71
128
1771
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
80
1374
0.56
6.06
1.8
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
112
687
1.68
6.01
2.9
3.3
pmol/l
4.2
4.6
2.57
100
603
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
19
54
3.55
5.89
1.1
1.0
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
412
5067
0.75
5.88
1.8
2.0
pmol/l
93.9
94.6
0.10
219
2682
(3052851) Hemolysis interference index of Serum or Plasma
71
383
1.89
5.87
3.5
3.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
824
9250
0.78
5.83
3.6
4.0
mm/h
11.4
12.0
0.62
765
8540
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
202
2.21
5.63
1.5
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
282
3647
0.73
5.58
2.6
3.1
ng/l
831.4
1555.0
5.23
245
3096
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
285
2165
1.38
5.53
2.5
2.9
e6/l
1.1
1.0
0.14
162
1244
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
72
1240
0.56
5.52
1.4
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
24
610
0.38
5.50
1.3
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
19
57
3.36
5.45
1.6
15.6
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
5
16.07
5.41
1.3
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
272
2059
1.39
5.39
2.6
3.2
e6/l
2.2
2.2
0.00
150
1142
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
56
288
1.98
5.35
1.2
1.5
—
—
—
0
0
(3020891) Body temperature
87
515
1.73
5.34
5.1
4.7
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
247
3234
0.72
5.24
1.8
2.2
mg/l
2.8
3.0
0.68
209
2746
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
35
4.03
5.17
1.0
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
221
2936
0.71
5.11
1.5
1.5
nmol/l
19.9
20.4
0.22
198
2494
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
15
40
3.78
5.09
2.1
2.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1261
13332
0.75
5.07
21.6
13.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
174
1233
1.46
4.98
4.9
4.1
mmol/l
2.4
2.0
1.05
146
973
(3009214) Lutropin [Units/volume] in Serum or Plasma
67
376
1.82
4.94
2.3
1.6
u/l
7.6
7.8
0.04
53
301
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
39
784
0.48
4.94
1.3
1.4
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
17
51
3.36
4.89
3.4
3.4
ug/l
1.2
1.8
0.49
17
46
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
204
2724
0.71
4.84
1.2
1.3
u/ml
1.9
1.7
0.08
42
725
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
858
9477
0.80
4.75
4.2
3.8
pmol/l
14.6
14.8
1.64
790
8587
(40761995) Spermatozoa Progressive [#/volume] in Semen
16
47
3.43
4.75
1.6
3.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
231
2.02
4.73
1.7
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
286
2235
1.34
4.60
1.5
1.9
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
48
248
1.96
4.57
4.1
3.3
e9/l
4.6
4.3
0.30
48
248
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
38
180
2.14
4.56
1.5
2.0
—
1200.0
—
0
9
(3000850) Epithelial cells [#/volume] in Urine
339
2718
1.31
4.55
2.5
2.7
e6/l
5.5
5.4
0.05
310
2407
(3021447) Carbon dioxide [Partial pressure] in Venous blood
172
1240
1.43
4.50
4.9
4.0
kpa
5.7
5.9
1.68
166
1199
(40765096) Chromosome analysis panel by Banding
15
44
3.43
4.47
1.1
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
422
5024
0.78
4.40
2.1
2.3
nmol/l
74.6
76.4
0.64
382
4501
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
84
521
1.65
4.39
1.9
2.0
ug/l
0.9
1.9
0.63
71
458
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
49
259
1.92
4.38
5.2
3.5
%
58.3
57.9
0.06
49
259
(3007853) Bacteria identified in Skin by Aerobe culture
202
1506
1.39
4.37
1.6
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
12
7.54
4.35
1.1
1.2
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
9
8.93
4.28
1.5
5.2
—
—
—
0
0
(4010399)
50
884
0.55
4.24
1.4
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
26
108
2.43
4.23
1.7
2.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
73
1157
0.61
4.09
1.5
1.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
334
0.30
4.08
1.2
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
10
8.03
4.06
1.1
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
15
47
3.21
4.06
3.2
6.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
62
363
1.74
4.03
1.3
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
278
0.32
3.97
1.2
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
31
144
2.18
3.94
1.9
1.5
nmol/l
0.2
0.3
1.18
24
113
(3048689) Calprotectin [Mass/mass] in Stool
103
1500
0.67
3.92
2.6
2.4
ug/g
227.2
130.6
0.74
89
1187
(1616796) Gas panel - Central venous blood
52
292
1.81
3.89
2.2
3.9
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
76
475
1.63
3.88
2.3
3.4
u/ml
17.1
8527.7
0.84
62
404
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
120
2.27
3.81
3.0
3.8
%
64.8
52.7
2.02
20
92
(3022145) Colonoscopy Study observation
93
1369
0.66
3.74
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
48
268
1.82
3.68
1.3
1.5
u/ml
87.4
105.1
—
10
49
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
33
162
2.06
3.67
2.4
1.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
124
1720
0.70
3.65
1.2
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
178
1344
1.36
3.58
4.4
3.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
19
439
0.43
3.57
1.2
1.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
98
665
1.50
3.53
6.3
4.6
mmol/l
25.3
24.1
4.14
89
607
(3014148) Varicella zoster virus Ab [Titer] in Serum
32
158
2.05
3.51
1.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
21
463
0.45
3.51
1.7
1.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
213
2696
0.76
3.49
1.5
1.7
pmol/l
64246303.6
25989638.8
0.25
179
2224
(3028433) Virus identified in Specimen by Culture
14
47
3.00
3.41
1.2
1.4
—
—
—
0
0
(3000492) Spirometry study
84
1235
0.66
3.37
1.5
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
9
18
5.02
3.37
1.2
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
18
5.02
3.37
1.2
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
9
18
5.02
3.37
1.1
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1112
11779
0.82
3.30
27.6
15.3
%
39.3
40.1
2.05
792
8514
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
125
903
1.42
3.28
1.9
1.7
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
69
441
1.59
3.27
2.2
1.5
iu/l
18.1
24.1
1.10
61
367
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
7
8.60
3.26
1.0
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
38
3.17
3.21
1.2
1.4
%
80.6
90.5
—
5
20
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
38
3.17
3.21
1.2
1.1
%
96.2
90.4
—
5
20
(3019225) pH of Specimen
161
1220
1.36
3.18
4.2
4.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
29
3.46
3.05
1.1
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
21
4.30
2.99
1.0
1.1
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
5
5
10.03
2.98
1.6
1.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
108
775
1.42
2.97
2.1
1.8
g/l
1.9
1.4
0.34
102
716
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
33
176
1.89
2.96
1.8
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
170
2171
0.76
2.96
1.4
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
25
484
0.51
2.94
1.4
1.8
mg/l
3.5
3.4
0.03
20
348
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
374
0.45
2.88
1.2
1.8
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1305
13544
0.81
2.77
29.7
16.5
umol/l
71.9
79.2
18.88
1305
13539
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
135
1022
1.35
2.71
5.6
3.8
mmol/l
1.2
1.2
0.08
126
882
(3042936) Bacteria identified in Isolate by Culture
228
1855
1.27
2.70
1.7
2.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
933
8678
1.18
2.68
4.4
4.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1307
13551
0.81
2.65
19.3
10.2
u/l
32.1
27.3
11.06
1283
13072
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
126
1647
0.75
2.60
1.7
1.8
%
1.9
1.5
2.14
103
1444
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
200
1.77
2.57
1.8
1.5
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
20
4.01
2.57
1.0
1.1
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
11
5.47
2.54
1.2
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
56
2.51
2.53
1.1
1.1
miu/ml
1287.6
1554.1
0.31
14
56
(3020393) Adenovirus Ag [Presence] in Stool
7
16
4.39
2.47
1.6
2.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
12
45
2.68
2.45
1.5
2.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
190
0.37
2.41
2.3
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
42
663
0.62
2.41
1.5
2.1
—
—
—
0
0
(4094501)
16
333
0.48
2.38
1.1
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
17
4.13
2.36
1.0
1.1
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
22
112
1.98
2.31
1.6
1.2
g/l
2.2
2.9
1.04
14
78
(3024139) IgG subclass 3 [Mass/volume] in Serum
22
112
1.98
2.31
1.6
1.2
g/l
0.3
0.4
0.35
14
78
(3027135) IgG subclass 1 [Mass/volume] in Serum
22
112
1.98
2.31
1.6
1.2
g/l
5.9
6.8
0.73
14
80
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
203
0.39
2.29
1.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
155
0.32
2.28
1.4
1.5
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
22
113
1.96
2.26
1.8
1.3
ug/l
3.0
2.8
0.08
17
97
(4062490)
22
113
1.96
2.26
1.6
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
53
782
0.67
2.24
1.4
1.3
u/ml
314.9
253.9
0.16
48
720
(3013139) Helicobacter pylori Ag [Presence] in Stool
53
777
0.67
2.18
1.2
1.2
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
197
0.40
2.17
1.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
197
0.40
2.17
1.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
129
1637
0.77
2.17
1.3
1.3
titre
676.0
466.1
0.34
20
325
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
77
556
1.40
2.12
3.4
3.7
%
53.0
49.4
0.70
77
548
(3027945) Reticulocytes/100 erythrocytes in Blood
176
1432
1.26
2.12
3.2
2.7
%
1.7
1.8
0.20
165
1281
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1141
11910
0.86
2.11
23.7
13.2
ml/min/173m2
89.5
81.6
33.56
1012
9815
(3000475) Leukocytes [#/volume] in Synovial fluid
15
302
0.49
2.06
1.5
1.7
e6/l
5123.6
13909.5
—
10
219
(3034891) Synovial lining cells/100 cells in Synovial fluid
0
56
0.00
2.06
0.0
1.3
—
1.9
—
0
11
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
105
1359
0.76
2.05
1.7
2.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
20
3.51
2.05
1.0
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
15
4.01
2.04
1.2
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
33
526
0.62
2.02
1.4
2.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
10
38
2.64
2.01
1.3
1.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
148
0.34
2.00
1.0
1.6
%
45.4
61.8
—
5
99
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
258
0.46
1.99
1.1
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
112
1.89
1.96
2.6
1.7
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
9
203
0.44
1.96
1.3
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
241
0.45
1.93
1.1
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
241
0.45
1.93
1.1
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
241
0.45
1.93
1.1
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
241
0.45
1.93
1.1
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
51
0.00
1.88
0.0
2.5
—
177.6
—
0
43
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
127
1580
0.79
1.85
1.3
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
12
4.18
1.82
2.2
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
38
570
0.66
1.79
1.2
1.1
titre
—
166.8
—
0
12
(3022217) INR in Platelet poor plasma by Coagulation assay
194
1627
1.22
1.79
14.7
25.0
inr
1.3
1.3
0.28
39
220
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
165
0.42
1.79
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
10
41
2.45
1.75
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
35
531
0.65
1.75
2.7
2.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
15
74
2.04
1.75
2.4
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
74
2.04
1.75
2.3
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
62
448
1.40
1.74
2.1
3.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
44
636
0.68
1.73
1.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
10
217
0.46
1.73
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
97
1237
0.77
1.73
1.6
2.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
9
192
0.47
1.73
1.1
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
8
30
2.67
1.72
1.5
2.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
24
2.92
1.72
1.4
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
108
852
1.29
1.71
3.2
4.8
mmol/l
1.9
1.7
0.34
89
629
(3051651) Icteric interference index of Serum or Plasma
17
89
1.92
1.70
4.9
3.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
17
306
0.55
1.69
1.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
433
4777
0.87
1.67
3.8
3.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
19
3.17
1.66
1.0
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
64
470
1.38
1.65
1.8
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
11
226
0.48
1.65
1.3
1.6
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
7
25
2.81
1.65
1.0
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.80
1.64
2.1
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
112
1.80
1.64
2.1
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
112
1.80
1.64
2.1
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
301
3403
0.86
1.63
3.3
3.3
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
32
2.51
1.59
1.9
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
183
1.60
1.58
2.0
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
569
6148
0.88
1.57
4.8
4.9
estimate
0.0
0.0
0.50
121
1159
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
126
1537
0.80
1.57
3.5
4.3
%
30.6
32.0
0.76
97
1040
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
46
324
1.43
1.52
1.1
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
128
1049
1.24
1.50
3.2
2.6
e9/l
70.9
69.8
0.14
103
815
(3026493) Urate [Moles/volume] in Serum or Plasma
298
3349
0.86
1.49
2.8
2.7
umol/l
4431.7
6169.4
0.31
262
2908
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
65
2.01
1.48
1.1
3.1
u/ml
915.8
1163.1
0.24
13
65
(3008898) HLA-B27 [Presence]
29
438
0.66
1.46
1.1
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
73
1.93
1.44
2.6
2.8
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
26
164
1.59
1.43
3.2
2.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
22
2.73
1.43
1.8
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
37
528
0.69
1.41
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
212
0.52
1.40
1.5
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
29
2.42
1.39
1.4
3.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
29
2.42
1.39
1.1
2.4
umol/l
22.6
18.4
—
7
29
(3035350) Ketones [Presence] in Urine by Test strip
573
6152
0.89
1.38
3.6
3.6
estimate
0.0
0.0
0.00
121
1144
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
89
1.81
1.37
2.3
1.6
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
6
23
2.61
1.37
1.5
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
6
23
2.61
1.37
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
6
23
2.61
1.37
1.5
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
145
1218
1.21
1.36
2.3
2.3
g/l
0.2
0.2
1.29
138
1131
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
38
0.00
1.34
0.0
3.2
—
79.9
—
0
8
(3036670) Protein [Mass/volume] in Synovial fluid
0
38
0.00
1.34
0.0
1.2
—
37.0
—
0
23
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
21
333
0.63
1.34
1.3
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
144
1.61
1.32
1.3
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
292
1.41
1.31
1.2
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
108
886
1.23
1.29
3.2
4.8
ph
7.4
7.4
1.61
13
108
(3022948) Iron [Moles/volume] in Serum or Plasma
171
1980
0.85
1.26
1.8
2.6
umol/l
15.1
13.1
2.20
157
1845
(3019150) Specific gravity of Urine by Refractometry
242
2728
0.87
1.26
3.8
3.9
kg/l
1.0
1.0
0.29
40
401
(3035320) C reactive protein [Mass/volume] in Body fluid
16
92
1.75
1.25
1.4
2.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
582
6215
0.90
1.24
3.6
3.6
estimate
0.0
0.0
0.80
117
1111
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
25
2.41
1.24
1.3
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
131
1.61
1.23
4.4
3.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
2.3
1.8
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
2.3
1.8
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
39
535
0.72
1.21
2.2
1.8
—
—
—
0
0
(1002224) Polysomnography panel
41
556
0.73
1.19
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
286
0.63
1.18
1.1
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
50
2.01
1.16
2.3
1.8
—
—
—
0
0
(4306422)
27
182
1.49
1.16
1.1
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
118
991
1.21
1.14
3.4
2.7
ml/min/173m2
68.9
66.0
0.25
31
398
(3038515) Glucose [Moles/volume] in Venous blood
36
258
1.40
1.14
3.7
3.2
mmol/l
7.2
7.6
0.53
36
253
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
275
1.39
1.14
1.4
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
36
0.00
1.14
0.0
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1049
10850
0.91
1.13
33.7
18.3
g/l
335.0
333.0
10.56
1038
10752
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
114
0.44
1.12
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
158
1820
0.85
1.11
1.7
2.6
g/l
2.3
2.3
0.10
144
1701
(40768793) Breast Pathology biopsy report
16
256
0.62
1.10
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
152
1.52
1.09
2.6
2.5
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
22
326
0.67
1.07
2.5
2.4
ug/min
445.9
110.4
—
10
197
(3021901) Oxygen saturation in Capillary blood
33
236
1.41
1.07
1.5
3.7
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
80
976
0.81
1.06
1.1
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
38
280
1.37
1.04
1.3
1.4
u/ml
275.8
256.6
0.09
23
174
(3008037) Lactate [Moles/volume] in Venous blood
37
272
1.37
1.03
3.6
3.1
mmol/l
1.5
1.6
0.31
37
266
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
5
107
0.47
1.01
1.0
1.4
%
28.6
31.5
—
5
69
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
35
2.00
1.00
1.1
1.1
—
—
—
0
0
(4146454)
7
132
0.53
0.99
2.4
2.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
26
181
1.44
0.98
1.2
3.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
26
181
1.44
0.98
1.0
1.1
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
61
1.81
0.98
1.0
1.1
—
18.4
—
0
7
(4211845)
10
54
1.86
0.96
2.7
3.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
69
1.74
0.96
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
35
467
0.74
0.96
3.2
2.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
50
390
1.29
0.96
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
94
789
1.20
0.95
1.5
1.6
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
77
930
0.82
0.95
3.2
4.3
ng/l
89.7
90.3
0.02
72
823
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
2.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
2.4
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
2.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
2.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
33
442
0.74
0.93
3.3
2.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
144
0.55
0.93
1.3
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
192
1.41
0.92
1.7
1.7
g/l
0.5
0.8
1.25
18
150
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
16
244
0.65
0.92
1.1
1.2
—
6.6
—
0
17
(3002523) Influenza virus A Ag [Presence] in Specimen
15
231
0.65
0.90
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
231
0.65
0.90
1.3
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
36
473
0.76
0.90
3.1
2.4
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
25
347
0.72
0.89
2.1
1.9
pmol/l
172.5
211.5
1.32
25
330
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
882
8496
1.08
0.89
4.1
3.2
u/l
69.2
49.9
2.89
839
7955
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
151
1710
0.87
0.88
1.9
2.6
%
26.1
23.3
1.19
130
1475
(3007566) Smooth muscle Ab [Titer] in Serum
45
351
1.29
0.88
1.2
1.2
titre
50.0
71.5
—
9
34
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
33
437
0.75
0.87
1.8
1.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
87
1.61
0.87
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
137
1200
1.15
0.86
2.1
2.5
u/l
35.1
78.2
0.55
112
1031
(3004716) Salmonella sp identified in Stool by Organism specific culture
51
635
0.80
0.85
1.2
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
55
443
1.25
0.84
1.2
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
141
1241
1.15
0.83
2.5
4.3
ug/l
3.0
24.1
2.37
102
1025
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
172
1536
1.13
0.82
10.2
7.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
375
0.74
0.81
3.7
2.3
—
—
—
0
0
(3013512) EKG study
390
3643
1.09
0.81
3.5
3.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
213
2346
0.89
0.81
1.7
1.7
nmol/l
1072.2
1184.1
1.23
163
1765
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
62
510
1.22
0.80
2.1
1.9
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
0
26
0.00
0.78
0.0
3.3
—
14.9
—
0
21
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
26
0.00
0.78
0.0
1.1
—
36.4
—
0
26
(3007164) IgA [Mass/volume] in Serum or Plasma
225
2458
0.90
0.75
2.0
1.4
g/l
2.2
2.5
0.46
141
1509
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
25
2.00
0.72
1.0
1.2
%
113.6
93.2
—
5
25
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
108
0.55
0.72
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
38
478
0.79
0.72
3.3
2.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
39
309
1.27
0.71
2.3
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
26
1.93
0.70
1.8
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
118
1041
1.14
0.70
1.9
3.3
ng/l
169.1
217.8
0.62
105
953
(3027008) Opiates [Presence] in Urine
38
476
0.79
0.70
3.0
2.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
330
0.75
0.68
2.1
3.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
42
1.67
0.68
1.1
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
42
1.67
0.68
1.4
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
37
463
0.79
0.68
1.8
1.8
nmol/l
39.5
38.7
0.10
37
445
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
119
0.59
0.67
1.3
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1295
12731
1.09
0.67
26.0
14.5
mg/l
21.0
24.7
4.96
1201
10080
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
330
1.25
0.66
4.0
4.5
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
94
0.53
0.66
1.0
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
15
211
0.71
0.62
1.1
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
49
1.64
0.62
3.1
3.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
10
63
1.59
0.61
2.2
2.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
68
791
0.85
0.61
1.2
1.2
iu/ml
202.6
134.8
0.35
18
312
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
24
182
1.32
0.61
1.0
1.3
u/ml
3.0
6.1
—
8
81
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
10
151
0.66
0.59
1.1
1.2
—
50.1
—
0
8
(4198724)
8
53
1.51
0.58
1.0
1.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
238
1.27
0.57
1.4
1.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
48
569
0.84
0.55
1.9
1.9
g/l
1.5
1.5
0.11
43
508
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
5
90
0.55
0.55
18.2
14.3
nmol/l
607.6
799.5
—
5
84
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
160
0.69
0.55
1.5
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
10
65
1.54
0.55
1.0
1.2
nmol/l
127.1
147.7
—
10
65
(44816559) Phosphatidylethanol [Mass/volume] in Blood
20
262
0.76
0.55
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
125
1129
1.12
0.55
2.0
2.3
ug/l
4.0
7.7
5.81
105
1000
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
186
1.29
0.54
1.1
1.2
u/ml
7.7
4.9
—
7
60
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
64
553
1.16
0.54
1.7
2.0
u/l
32.5
39.2
2.11
56
494
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
9
61
1.48
0.53
1.3
1.1
u/l
110.1
89.7
—
9
48
(3019420) Tryptase [Mass/volume] in Serum or Plasma
9
61
1.48
0.53
1.1
1.5
ug/l
4.4
10.3
—
9
50
(3022313) Gas panel - Capillary blood
75
657
1.15
0.53
3.9
5.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
63
1.43
0.52
1.2
1.7
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
20
152
1.32
0.52
1.9
1.3
mu/l
19.1
49.2
2.14
20
133
(3012441) Differential panel - Pleural fluid
9
133
0.67
0.52
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
9
134
0.67
0.52
1.1
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
126
1.35
0.51
1.6
2.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
628
0.86
0.51
2.2
2.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
13
180
0.72
0.51
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
214
0.75
0.51
2.1
3.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
325
1.20
0.50
1.3
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
316
3332
0.94
0.48
4.0
3.9
estimate
0.0
0.0
1.28
112
1112
(3032773) Endomysium IgG Ab [Titer] in Serum
7
107
0.65
0.48
1.0
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
376
3940
0.94
0.48
2.7
2.6
u/l
56.4
57.5
0.20
351
3661
(3044889) 12 lead EKG panel
908
8875
1.05
0.47
3.5
3.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
21
266
0.79
0.47
1.7
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
40
337
1.19
0.46
1.1
1.3
—
6.2
—
0
5
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
221
0.77
0.46
1.2
1.7
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
19
148
1.29
0.43
1.5
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
78
1.41
0.43
1.2
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
11
78
1.41
0.43
1.2
1.6
u/l
4.8
8.0
—
5
41
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
78
1.41
0.43
1.2
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
6
92
0.65
0.42
1.2
1.1
—
100.4
—
0
5
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
95
0.63
0.42
1.3
1.5
g/l
0.8
1.0
—
6
95
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
0
15
0.00
0.41
0.0
2.1
—
2.9
—
0
6
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
36
305
1.18
0.41
1.3
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
59
1.36
0.41
1.3
1.9
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
17
0.00
0.40
0.0
1.0
—
9.0
—
0
6
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
18
0.00
0.40
0.0
1.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
16
124
1.29
0.38
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
118
1088
1.09
0.38
3.8
3.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
170
0.76
0.38
1.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
15
116
1.30
0.37
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
81
1.36
0.36
1.2
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
5
77
0.65
0.35
1.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
122
0.74
0.35
1.6
1.7
—
—
—
0
0
(4268621)
16
126
1.27
0.35
2.1
2.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
16
127
1.26
0.33
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
371
0.86
0.33
1.4
1.4
ug/g
293.1
295.3
0.03
22
213
(1617658) Protocol used for examination of sentinel lymph nodes
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
88
0.68
0.33
1.2
1.1
—
43.2
—
0
5
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
89
0.67
0.33
1.0
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
7
57
1.23
0.29
3.6
2.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
120
0.75
0.27
1.6
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
31
271
1.15
0.27
1.5
1.4
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
300
0.86
0.27
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
11
139
0.79
0.27
1.2
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
24
206
1.17
0.26
1.1
1.1
iu/ml
1.0
108.1
—
6
57
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
29
253
1.15
0.26
1.0
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
14
171
0.82
0.26
1.6
1.4
nmol/l
0.8
0.6
0.22
14
160
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
72
0.69
0.26
1.4
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
144
1518
0.94
0.26
1.5
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
75
0.67
0.26
1.2
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
275
2848
0.96
0.25
3.5
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
63
684
0.92
0.25
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
35
392
0.89
0.24
1.2
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
16
133
1.21
0.24
1.1
1.1
%
99.3
96.9
0.14
16
126
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
189
1.17
0.24
1.1
1.1
g/l
1.5
1.5
0.17
22
171
(3020876) Protein [Mass/time] in 24 hour Urine
13
106
1.23
0.23
1.5
2.0
—
1.4
—
0
7
(40768806) Pleura Pathology biopsy report
11
136
0.81
0.23
1.6
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
17
144
1.18
0.22
1.3
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
210
1.15
0.21
1.1
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
24
273
0.88
0.21
2.5
2.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
107
1.22
0.21
1.0
1.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
16
135
1.19
0.21
2.4
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(4212803)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
471
0.91
0.21
1.5
2.4
g/l
3.8
3.8
0.10
31
345
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
27
304
0.89
0.21
1.7
1.8
iu/l
4.2
5.1
0.22
14
101
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
12
0.00
0.21
0.0
13.3
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
32
287
1.12
0.21
1.5
2.2
g/l
138.5
128.8
1.18
25
213
(3017509) Phencyclidine [Presence] in Urine
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
100.8
—
0
13
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
0.5
—
0
6
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
18
208
0.86
0.20
1.1
1.1
—
13.4
—
0
13
(3014765) Yersinia sp identified in Stool by Organism specific culture
35
386
0.90
0.20
1.2
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
6
50
1.20
0.19
1.7
1.8
nmol/l
1.0
5.2
—
6
41
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
35
385
0.91
0.19
1.2
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
154
0.84
0.19
1.5
1.3
nmol/l
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
53
1.13
0.18
1.2
1.6
—
1688041.7
—
0
6
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
18
156
1.16
0.18
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
18
156
1.16
0.18
1.7
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
18
156
1.16
0.18
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
272
2795
0.97
0.18
2.0
1.8
mg/l
2.1
1.2
1.68
219
2138
(3000012) Reticulocyte production index
7
59
1.19
0.18
1.4
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
61
1.15
0.17
1.1
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
18
157
1.15
0.17
1.7
1.4
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
37
339
1.09
0.17
2.2
2.4
u/l
7.7
3235.2
3.43
11
139
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
82
1.22
0.17
1.3
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
5
66
0.76
0.17
1.2
2.8
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1312
13047
1.03
0.17
28.3
16.7
mmol/l
139.0
139.6
11.28
1294
12688
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
215
1.12
0.16
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
22
196
1.12
0.16
1.3
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
70
1.14
0.16
1.4
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
18
158
1.14
0.16
1.7
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
18
158
1.14
0.16
1.7
1.4
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
8
73
1.10
0.15
1.3
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
472
0.93
0.15
1.5
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
44
472
0.93
0.15
1.5
2.4
g/l
7.5
7.4
0.19
33
360
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
171
0.88
0.14
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
87
0.80
0.14
1.7
1.6
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
36
337
1.07
0.11
1.6
2.5
g/l
0.0
0.0
0.00
29
314
(3002256) Pathology report gross observation
154
1581
0.97
0.11
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
101
1043
0.97
0.10
3.6
3.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.6
2.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
10
114
0.88
0.09
1.8
2.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
87
1.15
0.09
1.4
1.2
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
442
0.95
0.09
1.5
2.5
g/l
3.0
3.1
0.53
33
353
(3004588) Protein electrophoresis panel - Serum or Plasma
87
843
1.03
0.09
2.2
2.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
83
804
1.03
0.08
3.0
3.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
12
133
0.90
0.07
1.3
1.3
e6/l
48061.7
76412.3
—
6
79
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
439
0.96
0.07
1.5
2.4
g/l
10.8
10.3
0.19
35
380
(3035880) pH of Pleural fluid
6
74
0.81
0.07
1.8
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
15
137
1.10
0.07
2.0
2.2
mg/l
15.0
20.8
—
5
31
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
8
76
1.05
0.07
1.0
1.3
—
275.0
—
0
6
(44813793)
7
82
0.85
0.07
1.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
87
1.03
0.07
1.4
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
35
334
1.05
0.06
1.5
2.5
g/l
0.0
0.0
0.00
29
313
(3030981) Hyaline casts [#/volume] in Urine by Automated count
66
680
0.97
0.06
2.8
3.0
e6/l
0.5
0.3
0.50
66
663
(3000330) Specific gravity of Urine by Test strip
64
621
1.03
0.06
4.2
3.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
102
0.88
0.06
1.2
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
103
0.87
0.06
1.2
1.2
nmol/l
260.0
390.0
—
9
91
(3028707) Methadone [Presence] in Urine by Screen method
23
217
1.06
0.06
4.2
3.0
—
—
—
0
0
(4024509)
11
100
1.10
0.05
1.2
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
110
1082
1.02
0.04
1.3
1.7
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1066
10631
1.01
0.04
32.7
17.5
%
13.9
13.7
4.25
1051
10393
(3017446) Testosterone [Moles/volume] in Serum or Plasma
117
1152
1.02
0.04
2.4
2.3
nmol/l
12.4
13.3
0.65
97
1028
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
34
352
0.97
0.04
1.3
1.3
miu/ml
135.4
219.1
—
10
160
(3004775) Volume in Urine collected for unspecified duration
10
109
0.92
0.04
2.3
2.3
ml
621.2
627.3
—
5
65
(3024928) Oxygen saturation in Venous blood
29
279
1.04
0.04
3.1
3.0
—
—
—
0